- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Biota Pharmaceuticals Inc+ Add to Watchlist
BOTA:US2.2500 USD 0.0100 0.44%
As of 20:10:00 ET on 12/26/2014.
Company Profile for Biota Pharmaceuticals Inc (BOTA)
Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections.
Biota Pharmaceuticals Inc
Key Executives for Biota Pharmaceuticals Inc (BOTA)
|Russell H PlumbChairman||Peter AzzarelloChief Accounting Officer|
|Joseph M PattiPresident/CEO|